A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial

Michael P. Boyle, Scott C. Bell, Michael W. Konstan, Susanna A. McColley, Steven M. Rowe, Ernst Rietschel, Xiaohong Huang, David Waltz, Naimish R. Patel, David Rodman

Research output: Contribution to journal › Article › peer-review

291 Scopus citations

Fingerprint

Dive into the research topics of 'A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences